By resolution WHA 59.24, the WHO’s Intergovernmental Working Group on Public Health, Innovation, and Intellectual Property (IGWG) has the goal of producing a Global Strategy and Plan of Action that will implement the CIPIH report recommendations and “secure an enhanced and sustainable basis for needs-driven, essential health research and development relevant to diseases that disproportionately affect developing countries, proposing cle Continue Reading →
On May 30, KEI hosted a brown bag lunch discussion on guidelines for the new U.S. trade policy recently released by the Congressional Ways and Means Committee and the Bush Administration. The event began with brief statements by panelists Fabiana… Continue Reading →
Monday, 30 April 2007 “The sanctioning of countries for using legitimate and important flexibilities in the TRIPS agreement brings shame to all U.S. citizens who are increasingly seen in Thailand and elsewhere as bullies and hypocrites.” The following is the… Continue Reading →
Here is a link to the text of the WHO EB’s draft resolution on the resport of the WHO Commission on Intellectual Property, Innovation and Public Health (CIPIH). http://www.cptech.org/ip/health/who/WHOcipih280406.html from the mini EB meeting on April 28. The US government… Continue Reading →
March 2006
CPTech Response to 2006 PhRMA “Special 301” Submission for Chile
The “Special 301” Report is a report that the office of the U.S. Trade Representative (USTR) submits annually to the House Ways and Means Committee and the Senate Finance Committee on the adequacy and effectiveness of intellectual property rights protection around the world. The report identifies those countries that the USTR consider “deny adequate and effective protection for IPR or deny fair and equitable market access for U.S. persons that rely on intellectual property protection”.
Continue Reading →
This is a joint statement by that NGOs presented to negotiators in 2005, as the WTO considered an amendment on TRIPS and public health, to address cases where medicines would be exported to countries with “insufficient or no manufacturing capacity.”… Continue Reading →
R 281104Z JUN 05 – June 28, 2005FM AMEMBASSY BRASILIATO SECSTATE WASHDC 1902SUBJECT: BRAZIL GIVES ABBOTT TEN DAYS BEFORE BREAKING PATENT 1. (U) SENSITIVE BUT UNCLASSIFIED 2. (U) Summary. On Friday June 24, the GoB announced a declaration of “public… Continue Reading →
February 16, 2005 109th Congress, 1st Session Issue: Vol. 151, No. 17 — Daily Edition [Pages S1498-S1499] From the Congressional Record Online through the Government Publishing Office [www.gpo.gov] THE DOHA DECLARATION AND THE TRADE PROMOTION AUTHORITY ACT OF 2002 Mr.… Continue Reading →
This is a letter, dated July 22, 2004, by six consumer groups, asking Robert Zoellick and other members of the Bush Administration, to change US trade policy, so that research and development, rather than intellectual property rights, were the focus.… Continue Reading →
Sep 16, 2010 A New Trade Framework for Global Healthcare R&D[1] Access to Medicines and the Financing of Innovations in Health Care Workshop Hosted by the Program on Science, Technology, and Global Development, The Earth Institute at Columbia University, and… Continue Reading →